1
10
2
-
https://d1y502jg6fpugt.cloudfront.net/25425/archive/files/a7370f0b89e51f516d5feee476d9897d.pdf?Expires=1712793600&Signature=f%7EONgDiNqQ2Vp2nFSD%7ExclCBBCSH2PUXP1KS9w5v5tzu5JWoP1BECwLtaahXDHJtE4Q8hATv21mLbXwnhPyizVdt4X4EfRHNXbQFEHAh52jmy4wVtJRWgm9Wn3w%7Ezd3RSg8ApNiMEZ6YJKNo5ds-j7vbmXaLglZZRqSDKEfoorYA2HX9JeLGUnjevuh8a-K2at4knoDq6tagNf-6wuoLXS0MxW6Xv09IIizEuioMrCpbB7U1HZ2HQAjKtm58QAw2oBWBrjn10qCrlc5UExtCE41kA7e7bRTzU0EZndw22rQrNi1HMUMBm9BIX6UEgos3kFzkWxjycNy4TbFQwxmd6w__&Key-Pair-Id=K6UGZS9ZTDSZM
96339ca71005a2e7bbbee98d688e3c08
Website
A resource comprising of a web page or web pages and all related assets ( such as images, sound and video files, etc. ).
Local URL
The URL of the local directory containing all assets of the website
<a href="https://www.trivedieffect.com/science/biofield-energy-treatment-based-test-formulation-as-a-novel-and-efficient-approach-on-various-biomarkers-in-human-bones-heart-liver-lungs-and-brain-cells/">https://www.trivedieffect.com/science/biofield-energy-treatment-based-test-formulation-as-a-novel-and-efficient-approach-on-various-biomarkers-in-human-bones-heart-liver-lungs-and-brain-cells/</a>
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
Biofield Energy Treatment Based Test Formulation as a Novel and Efficient Approach on Various Biomarkers in human Bones, Heart, Liver, Lungs, and Brain Cells
Subject
The topic of the resource
Organ Health
Description
An account of the resource
<p style="text-align:justify;">Multiple organ dysfunction syndromes (MODS) are one of the common reasons for increased mortality rate against healthcare services. The present experiment aimed to determine the impact of the Biofield Energy Treated test formulation on the function of vital organs such as bones, heart, liver, lungs, and brain using standard activity parameters in specific cell-based assays. The test formulation and cells medium was divided into two parts; one untreated (UT) and other part received the Biofield Energy Treatment remotely by a renowned Biofield Energy Healer, Laura Nelson Streicher, and USA and were labeled as the Biofield Energy Treated (BT) test formulation/media. The test formulation was tested against various activities using cell line assay. The test formulation was tested for cell viability, and the results showed that the test formulation was found non-toxic against all the cell lines at the tested concentrations. Cytoprotective activity among the experimental groups showed a significant improved activity by 156.9% at 1 µg/mL in UT- medium (Med) + BT - test item/formulation (TI) group in human cardiac fibroblasts cells (HCF) cells, while 94.5% at 25.5 µg/mL in the UT-Med + BT-TI group in human hepatoma cells (HepG2), and 92.4% at 63.75 µg/mL in the BT-Med + BT-TI group as compared with the untreated test group in adenocarcinomic human alveolar basal epithelial cells (A549) cells as compared with the untreated test group. Alkaline phosphatase (ALP) activity in MG-63 cells was significantly increased by 80.2% and 93.5% at 10 and 50 µg/mL respectively in the UT-Med + BT-TI group, while in Ishikawa cells showed maximum increased ALP activity by 51.5% at 1 µg/mL in UT-Med + BT-TI group as compared to the untreated group. The percent protection of HCF (heart) cells (decreased of lactate dehydrogenase-LDH activity) was significantly increased by 156.9% and 18.3% at 1 and 10 µg/mL concentrations respectively, in UT-Med + BT-TI group, while BT-Med + UT-TI group showed increased protection by 24.5% and 17.7% at10 and 25.5 µg/mL respectively, and 67.1%, 32.2%, 47.7%, and 73.1% improved cellular protection 1, 10, 25.5, and 63.75 µg/mL respectively, in BT-Med + BT-TI group as compared to the untreated test group. Alanine amino transferase (ALT) in terms of percent protection of HepG2 (liver) cells (decreased of ALT activity) was reported by 93.1% and 64.1% at 1 µg/mL in the UT-Med + BT-TI and BT-Med + UT-TI groups, respectively as compared to the untreated group. Cellular protection of A549 (lungs) cells (increased of superoxide dismutase-SOD activity) in terms of percentage was increased by 20.6% (at 0.1 µg/mL) and 6.9% (at 10 µg/mL) in the UT-Med + BT-TI and BT-Med + BT-TI groups, respectively as compared to untreated group. Serotonin level was significantly increased by 59.3% (at 10 µg/mL), 55.6% (at 1 µg/mL), and 100.1% (at 0.1 µg/mL) in the UT-Med + BT-TI, BT-Med + UT-TI, and BT-Med + BT-TI groups, respectively compared to untreated in human neuroblastoma cells (SH-SY5Y). However, the relative quantification (RQ) of vitamin D receptor (VDR) was significantly increased by 150.6% (at 50 µg/mL), 380.1% (at 10 µg/mL), and 148.1% (at 50 µg/mL) in the UT-Med + BT-TI, BT-Med + UT-TI, and BT-Med + BT-TI groups, respectively as compared to the untreated in MG-63 cells. In conclusion, test formulation would be significantly useful for multiple organ health and improve overall health of bones, heart, liver, lungs, and brain after treatment with the Biofield Energy treated test formulation (The Trivedi Effect®). As a complementary and alternative therapy, Biofield Energy approach can be used against coronary artery disease, arrhythmias, congenital heart disease, cardiomyopathy, cirrhosis, liver cancer, hemochromatosis, asthma, chronic bronchitis, cystic fibrosis, osteoporosis, etc.</p>
Creator
An entity primarily responsible for making the resource
Laura Nelson Streicher, Mahendra Kumar Trivedi, Alice Branton, Dahryn Trivedi, Gopal Nayak, Mayank Gangwar, Snehasis Jana
Publisher
An entity responsible for making the resource available
Medwin Publishers
Date
A point or period of time associated with an event in the lifecycle of the resource
July 5, 2019
Language
A language of the resource
English
Type
The nature or genre of the resource
Journal Article
Identifier
An unambiguous reference to the resource within a given context
10.23880/oajpr-16000180
Biofield Energy Treatment
Bone Health
Brain health
Cardiac health
Liver health
Lungs health
The Trivedi Effect®
VDR receptors
-
https://d1y502jg6fpugt.cloudfront.net/25425/archive/files/54a14b00575c4ecac35db30a82efc04f.pdf?Expires=1712793600&Signature=GgjRY8p-LFVZWfRaBNFaUtpUQPRAKXGyHL2oHH7O5LpnuFLPvBvmgu46AQ7Yeg9yfDcxIBsfpQ4pTtkOS2O8lqOl3qqR1J1dU8UTPmXVcSLTVNse9v5L2Z3dO4IRdl7CPQzNiqYaGQ3II0qRB7ApcihqiiCE9h8ER0tCjM6dOiyqhJwlHlJX01CRyoAoALgwJVi0rO81oSaXBXuRw4nvhPioLuT52D3-kR9ouuQXZhqTNMQGzUd0xOicvHUzZmxvzy-3WJN-3Aq4uJCNXMY7pVSAjAUzKC-pTDU9LSEay9fE0c4dgM5eRvNUgIMJ7ovrjTe0sJkHUZG5F7NOYn81Xw__&Key-Pair-Id=K6UGZS9ZTDSZM
760591f6ca379c8ce48002adeb16606b
Website
A resource comprising of a web page or web pages and all related assets ( such as images, sound and video files, etc. ).
Local URL
The URL of the local directory containing all assets of the website
<a href="https://www.trivedieffect.com/science/impact-of-biofield-energy-treatment-based-test-formulation-on-vital-organ-health-specific-biomarkers-using-cell-line-study/">https://www.trivedieffect.com/science/impact-of-biofield-energy-treatment-based-test-formulation-on-vital-organ-health-specific-biomarkers-using-cell-line-study/</a>
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
Impact of Biofield Energy Treatment Based Test Formulation on Vital Organ Health Specific Biomarkers Using Cell Line Study
Subject
The topic of the resource
Organ Health
Description
An account of the resource
<p style="text-align:justify;">Multiple organ dysfunction syndrome or failure is one of the major concerns against healthcare services in order to maintain the normal function. The present study aimed to explore the impact of the Biofield Energy Treated test formulation on the function of vital organs such as bones, heart, liver, lungs, and brain using standard activity parameters in specific cell-based assays. The test formulation and cells medium was divided into two parts, one untreated (UT) and other part received the Biofield Energy Treatment remotely by a renowned Biofield Energy Healer, Ariadne Esmene Afaganis, Canada and was labeled as the Biofield Treated (BT) test formulation/media. The test formulation was tested for cell viability, and the data suggested that the test formulation was found safe and non-toxic against all the cell lines. Cytoprotective activity among the experimental groups showed a significant improved activity by 94.4% at 1 µg/mL in untreated medium (UT-Med) + Biofield Treated Test Item (BT-TI) group in human cardiac fibroblasts cells (HCF) cells, while 84.4% at 10 µg/mL in BT-Med + BT-TI groups in human hepatoma cells (HepG2), and 124% increased cytoprotective action at 1 µg/mL in UT-Med + BT-TI group in adenocarcinomic human alveolar basal epithelial cells (A549) cells as compared with the untreated test group. ALP activity in MG-63 cells was significantly increased by 85.9% at 10 µg/mL in the UT-Med + BT-TI group, while in Ishikawa cells showed maximum increased ALP activity by 59.2% at 0.1 µg/mL in BT-Med + BT-TI groups as compared to the untreated group. The percent protection of HCF (heart) cells (decreased of LDH activity) was significantly increased by 53% and 40.5% at 1 and 10 µg/mL concentrations respectively, in UT-Med + BT-TI group, while BT-Med + UT-TI group showed increased protection by 68.5%, 70.7%, and 16.8% at 0.1, 1, and 10 µg/mL respectively, and 86.5%, 62.5%, and 34.2% improved cellular protection at 0.1, 1, and 10 µg/mL respectively, in BT-Med + BT-TI group as compared to the untreated test group. The percent protection of HepG2 (liver) cells (decreased of ALT activity) was reported by 33.5%, 63.2%, and 99.2% at 10 µg/mL in the UT-Med + BT-TI, BT-Med + UT-TI, and BT-Med + BT-TI groups, respectively compared to the untreated group. Cellular protection of A549 (lungs) cells (increased of SOD activity) in terms of percentage was increased by increased by 39.8% (at 10 µg/mL), 44% (at 25.5 µg/mL), and 59.7% (at 25.5 µg/mL) in the UT-Med + BT-TI, BT-Med + UT-TI, and BT-Med + BT-TI groups, respectively compared to untreated group. Serotonin level was significantly increased by 59.2% (at 0.1 µg/mL), 190.3% (at 0.1 µg/mL), and 201% (at 1 µg/mL) in the UT-Med + BT-TI, BT-Med + UT-TI, and BT-Med + BT-TI groups, respectively compared to untreated in human neuroblastoma cells (SH-SY5Y). However, the relative quantification (RQ) of vitamin D receptor (VDR) was significantly increased by 159.1% (at 50 µg/mL), 212.7% (at 1 µg/mL), and 278.3% (at 10 µg/mL) in the UT-Med + BT-TI, BT-Med + UT-TI, and BT-Med + BT-TI groups, respectively as compared to the untreated in MG-63 cells. Thus, the present data concluded that the overall multiple organ health using various standard biomarkers in specific cell lines were significantly improved with respect to health of bones, heart, liver, lungs, and brain after treatment with the Biofield Energy treated test formulation (The Trivedi Effect®). Thus, it can be used as a complementary and alternative therapy approach against many multiple organ disorders such as coronary artery disease, arrhythmias, congenital heart disease, cardiomyopathy, cirrhosis, liver cancer, hemochromatosis, asthma, chronic bronchitis, cystic fibrosis, osteoporosis, etc.</p>
Creator
An entity primarily responsible for making the resource
Ariadne Esmene Afaganis, Mahendra Kumar Trivedi, Alice Branton, Dahryn Trivedi, Gopal Nayak, Mayank Gangwar, Snehasis Jana
Source
A related resource from which the described resource is derived
<a href="https://openaccesspub.org/jtrr/article/1131#idm1843080236">https://openaccesspub.org/jtrr/article/1131#idm1843080236</a>
Publisher
An entity responsible for making the resource available
Open Access Pub
Date
A point or period of time associated with an event in the lifecycle of the resource
Jul 13, 2019
Language
A language of the resource
English
Type
The nature or genre of the resource
Journal Article
Identifier
An unambiguous reference to the resource within a given context
10.14302/issn.2640-6403.jtrr-19-2946
Biofield Energy Treatment
Bone Health
Brain health
Cardiac health
Liver health
Lungs health
The Trivedi Effect®
VDR receptors